Ashton Thomas Private Wealth LLC Acquires 4,054 Shares of iShares Biotechnology ETF $IBB

Ashton Thomas Private Wealth LLC lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 12.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 35,767 shares of the financial services provider’s stock after buying an additional 4,054 shares during the quarter. Ashton Thomas Private Wealth LLC owned approximately 0.07% of iShares Biotechnology ETF worth $6,036,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Allspring Global Investments Holdings LLC lifted its stake in shares of iShares Biotechnology ETF by 46,806.0% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock valued at $7,927,000 after buying an additional 46,806 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at $1,907,000. Central Pacific Bank Trust Division lifted its stake in shares of iShares Biotechnology ETF by 296,500.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock valued at $2,503,000 after buying an additional 14,825 shares in the last quarter. SG Americas Securities LLC lifted its stake in shares of iShares Biotechnology ETF by 96.3% during the 3rd quarter. SG Americas Securities LLC now owns 28,569 shares of the financial services provider’s stock valued at $4,125,000 after buying an additional 14,016 shares in the last quarter. Finally, Florin Court Capital LLP purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at $11,116,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB opened at $169.02 on Tuesday. iShares Biotechnology ETF has a fifty-two week low of $116.25 and a fifty-two week high of $179.64. The firm’s fifty day moving average is $170.28 and its 200 day moving average is $168.30.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.